nisoldipine has been researched along with Insulin Resistance in 1 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is a cardiovascular risk factor commonly associated with insulin resistance, the metabolic syndrome, and type 2 diabetes mellitus." | 6.72 | Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension. ( Appel, D; Benndorf, RA; Böger, RH; Maas, R; Rudolph, T; Schulze, F; Schwedhelm, E; Silberhorn, E, 2006) |
| "Hypertension is a cardiovascular risk factor commonly associated with insulin resistance, the metabolic syndrome, and type 2 diabetes mellitus." | 2.72 | Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension. ( Appel, D; Benndorf, RA; Böger, RH; Maas, R; Rudolph, T; Schulze, F; Schwedhelm, E; Silberhorn, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benndorf, RA | 1 |
| Rudolph, T | 1 |
| Appel, D | 1 |
| Schwedhelm, E | 1 |
| Maas, R | 1 |
| Schulze, F | 1 |
| Silberhorn, E | 1 |
| Böger, RH | 1 |
1 trial available for nisoldipine and Insulin Resistance
| Article | Year |
|---|---|
Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors | 2006 |